Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemolytic Disease of the Newborn”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Active Not RecruitingNCT05891249
What this trial is testing

Evaluate the Safety and Effectiveness of Luspatercept for the Treatment of Transfusion-dependent (TD) Anemia Associated With Myelodysplastic Syndromes (MDS) & Beta-thalassemia (β-Thal) in India

Who this might be right for
Anemia
Bristol-Myers Squibb 85
Testing effectiveness (Phase 2)Study completedNCT00001958
What this trial is testing

Hydroxyurea to Treat Beta-Thalassemia (Cooley's Anemia)

Who this might be right for
Beta ThalassemiaHemoglobinopathy
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 100
Large-scale testing (Phase 3)UnknownNCT03728543
What this trial is testing

The Efficacy and Safety of Sugammadex in Children 0-2 Years Old

Who this might be right for
AnesthesiaPediatric CancerPediatric Tumor+3 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 62
Testing effectiveness (Phase 2)Study completedNCT02482298
What this trial is testing

Assess the Effect of Ticagrelor in Reducing the Number of Days With Pain in Patients With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
AstraZeneca 87
Early research (Phase 1)Study completedNCT05718687
What this trial is testing

A GBT021601 ADME Microtracer Study in Healthy Volunteers

Who this might be right for
Sickle Cell Disease
Pfizer 9
Large-scale testing (Phase 3)Looking for participantsNCT05378555
What this trial is testing

Oral Ketamine for Treatment of Vaso-Occlusive Pain

Who this might be right for
Vaso-occlusive Crisis
Boston Children's Hospital 10
Testing effectiveness (Phase 2)Ended earlyNCT01000155
What this trial is testing

Efficacy of Vorinostat to Induce Fetal Hemoglobin in Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseSickle Cell Anemia
Dana-Farber Cancer Institute 5
Not applicableStudy completedNCT02674607
What this trial is testing

The Potential Immunomodulatory Effects of Spirulina on Thalassemic Children

Who this might be right for
Beta Thalassemia Major
Tanta University 60
Not applicableUnknownNCT00596999
What this trial is testing

A Single-arm Safety Study of Transplantation Using Umbilical Cord Blood and Human Placental-derived Stem Cells From Partially Matched Related Donors in Persons With Certain Malignant Blood Diseases and Non-malignant Disorders

Who this might be right for
Hematologic Malignancies
Celgene Corporation 6
Large-scale testing (Phase 3)Not Yet RecruitingNCT07498309
What this trial is testing

Evaluation of the Efficacy of Iloprost in the Management of Vaso-occlusive Crises in Adult Patients With Sickle Cell Disease

Who this might be right for
Vaso-Occlusive CrisesSickle Cell Disease
University Hospital, Rouen 144
Early research (Phase 1)Study completedNCT01835496
What this trial is testing

Absorption, Metabolism, and Excretion of a Single Dose of Ferriprox® in Patients With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
ApoPharma 8
Not applicableStudy completedNCT04146246
What this trial is testing

Comparative Evaluation of the FINDER Instrument and FINDER G6PD Cartridge in Adults and Neonates

Who this might be right for
G6PDG6PD Deficiency
Baebies, Inc. 119
Early research (Phase 1)Study completedNCT03899246
What this trial is testing

Sickle Cell Pain: Intervention With Capsaicin Exposure

Who this might be right for
Neuropathic PainSickle Cell Disease
Children's Hospital of Michigan 10
Not applicableUnknownNCT06539169
What this trial is testing

FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases

Who this might be right for
Alpha-ThalassemiaBeta-ThalassemiaAmyloidosis+14 more
xCures 1,000
Not applicableUnknownNCT05635266
What this trial is testing

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

Who this might be right for
Age-Related Macular DegenerationAllergiesAlpha-Gal Syndrome+44 more
Sanguine Biosciences 20,000
Not applicableStudy completedNCT04973280
What this trial is testing

Study to Evaluate Additional Risk Minimisation Measures (aRMMs) for REBLOZYL Among Healthcare Professionals (HCPs)

Who this might be right for
Myelodysplastic SyndromesBeta-thalassemia
Celgene 187
Post-approval studies (Phase 4)Ended earlyNCT02443545
What this trial is testing

Long-term Safety and Efficacy of Ferriprox® in Iron Overloaded Patients With Sickle Cell Disease or Other Anemias

Who this might be right for
Iron OverloadSickle Cell DiseaseOther Anemias
ApoPharma 134
Testing effectiveness (Phase 2)Study completedNCT03432364
What this trial is testing

Assess the Safety, Tolerability, and Efficacy of ST-400 for Treatment of Transfusion-Dependent Beta-thalassemia (TDT)

Who this might be right for
Transfusion Dependent Beta-thalassemia
Sangamo Therapeutics 5
Testing effectiveness (Phase 2)Ended earlyNCT02850406
What this trial is testing

Study to Evaluate the Effect of GBT440 in Pediatrics With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Pfizer 147
Testing effectiveness (Phase 2)Study completedNCT02615847
What this trial is testing

Clinical Trial to Study the Safety and Tolerability of Memantin Mepha® in Sickle Cell Disease Patients

Who this might be right for
Sickle Cell Disease
University of Zurich 9
Next Page